POINT Biopharma Global Inc. Free Cash Flow 2021-2023 | PNT
POINT Biopharma Global Inc. free cash flow from 2021 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| POINT Biopharma Global Inc. Annual Free Cash Flow |
| 2022 |
170.75 |
| 2021 |
-53.50 |
| 2020 |
-18.10 |
| 2019 |
|
| POINT Biopharma Global Inc. Quarterly Free Cash Flow |
| 2023-09-30 |
-142.11 |
| 2023-06-30 |
-107.58 |
| 2023-03-31 |
-25.92 |
| 2022-12-31 |
170.75 |
| 2022-09-30 |
-64.09 |
| 2022-06-30 |
-34.15 |
| 2022-03-31 |
-11.43 |
| 2021-12-31 |
-53.50 |
| 2021-09-30 |
-39.49 |
| 2021-06-30 |
-22.69 |
| 2021-03-31 |
-11.15 |
| 2020-09-30 |
-9.88 |
| 2020-06-30 |
-4.21 |
